AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3297890
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion at 34 +/‐ 4 microU/ml
Trial: 31833053
Drug: Tailored therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored therapies and disease monitoring
Trial: 29273021
Drug: Standard community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard community mental health team care (treatment as usual)
Trial: 31267684
Drug: Sildenafil 50
RxNorm normalized name: sildenafil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 50 mg every other day
Trial: 31267684
Drug: Sildenafil 50
RxNorm normalized name: sildenafil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 50 mg every other day + l-arginine 3 g/day orally
Trial: 10783343
Drug: decapeptyl-GnRH (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: decapeptyl-GnRH (100 microgram) daily injected from day 1 to triggering of ovulation
Trial: 10783343
Drug: decapeptyl-GnRH (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: decapeptyl-GnRH (100 microgram) daily injected for the first 7 days
Trial: 24016560
Drug: Different treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different treatment options for flat type of sudden hearing loss
Trial: 8922792
Drug: Fluconazole 200
RxNorm normalized name: fluconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 200 mg daily
Trial: 1633070
Drug: Fluconazole 400
RxNorm normalized name: fluconazole 400 MG in 200 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 400 mg daily
Trial: 7742428
Drug: Fluconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (200 mg to 400 mg daily)
Trial: 2167795
Drug: Dye dilution
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dye dilution method (Indocyanine Green dye infusion into the femoral artery)
Trial: 19901104
Drug: RT followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT followed by adjuvant PCV chemotherapy
Trial: 21948942
Drug: Intravenous infliximab
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous infliximab
Trial: 9813532
Drug: Ropivacaine 2
RxNorm normalized name: fentanyl-ropivacaine 2 mcg/mL-0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2 mg kg-1
Trial: 31597621
Drug: Resistance exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance exercise training sessions three times per week with daily oral cholecalciferol supplementation
Trial: 31359435
Drug: Individual/Group Supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual/Group Supportive Therapy (IGST)
Trial: 24298766
Drug: Medication (loratadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (loratadine tablet and azelastine hydrochloride nasal spray)
Trial: 18165210
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine ophthalmic solution 0.4%
Trial: 12095313
Drug: VEGF-plasmid/liposome (VEGF-P/L)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF-plasmid/liposome (VEGF-P/L) - 2000 microg of VEGF plasmid, 2000 microl of DOTMA:DOPE
Trial: 7032640
Drug: Adriamycin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adriamycin (50 mg in 50 ml of saline for 30 min)
Trial: 17966758
Drug: Chlorpropamide 250
RxNorm normalized name: chlorpropamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpropamide 250 mg tablet (test formulation)
Trial: 16321616
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg olmesartan medoxomil
Trial: 16321616
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg olmesartan medoxomil
Trial: 16321616
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lisinopril plus 20 mg olmesartan medoxomil
Trial: 16321616
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lisinopril plus 40 mg olmesartan medoxomil
Trial: 11912111
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment during control period)
Trial: 9797755
Drug: Inhaled LPS
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled LPS (60 micrograms)
Trial: 30843501
Drug: 600 IU
RxNorm normalized name: Vitamin E 4600 IU/5 ML Oral Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 IU daily vitamin D3 supplementation
Trial: 30843501
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU daily vitamin D3 supplementation
Trial: 30843501
Drug: 2000 IU
RxNorm normalized name: D 2000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 IU daily vitamin D3 supplementation
Trial: 29356445
Drug: Repeated exposure
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated exposure to weather-related stressors (30 min of a 3°C decrease in temperature, simulated rain, or 2 hr of food removal, 4 times daily for 3 weeks)
Trial: 8846489
Drug: Mefloquine 25
RxNorm normalized name: mefloquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine 25 mg/kg (M25)
Trial: 8846489
Drug: Mefloquine 25
RxNorm normalized name: mefloquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine 25 mg/kg (M25) split dose
Trial: 2210983
Drug: Intralesional corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional corticosteroid injections combined with internal urethrotomy
Trial: 434434
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% (4 ml)
Trial: 434434
Drug: Tetracaine 0.5%
RxNorm normalized name: TETRACAINE 0.5% VISCOUS (FORTE) OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracaine 0.5% (4 ml)
Trial: 26834462
Drug: Cariprazine (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine (3, 6, or 9 mg/day)
Trial: 22882724
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg once-daily for 12 weeks
Trial: 18365859
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT) for 24 months
Trial: 15997446
Drug: Laparoscopic rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic rectal surgery
Trial: 8920706
Drug: Serotype G2
RxNorm normalized name: Rotavirus serotype G2 Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotype G2 vaccine
Trial: 27919453
Drug: Tartary buckwheat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tartary buckwheat (TB) intervention group (daily replacement of a portion of staple food with TB food)
Trial: 17984375
Drug: Flavonoid-rich dark
RxNorm normalized name: dark leaved mugwort pollen extract
DrugBank: Artemisia ludoviciana pollen (DB10762)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavonoid-rich dark chocolate (40 g, 70% cocoa)
Trial: 2973471
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic hormone (ANH) infusion (0.75 pmol/kg.min)
Trial: 30307347
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of scenario-based and conventional training (Arm 3)
Trial: 28162145
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy using a mobile application (CBT‐I‐MA)
Trial: 19399934
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg parecoxib infusion 30 min before induction of anesthesia and at 12 h after the first dose
Trial: 19399934
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion as placebo
Trial: 17645463
Drug: 1-week furazolidone-based
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-week furazolidone-based quadruple therapy (FABO1)
Trial: 17645463
Drug: 2-week furazolidone-based
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week furazolidone-based quadruple therapy (FABO2)
Trial: 14679124
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg/day) concomitantly with EC chemotherapy (epirubicin 75 mg/m² + cyclophosphamide 600 mg/m² on day 1, every 21 days for four cycles)
Trial: 7889884
Drug: High boron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High boron intake (approximately 3.25 mg boron/2000 kcal/day)
Trial: 7889884
Drug: Low boron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low boron intake (approximately 0.25 mg boron/2000 kcal/day)
Trial: 2986422
Drug: 100 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms CRF dosage
Trial: 26762123
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality exposure therapy (VRETp) combined with treatment as usual (TAU)
Trial: 18685353
Drug: Serotonin and
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin and noradrenaline-reuptake inhibitors
Trial: 27973619
Drug: Metformin 1000
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1000 mg/d
Trial: 15886247
Drug: Metformin 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1500 mg/d
Trial: 31769886
Drug: Metformin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (all doses)
Trial: 16594932
Drug: Lactic acid
RxNorm normalized name: Lactic Acid
DrugBank: Lactic acid (DB04398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactic acid gel (LVG)
Trial: 12477508
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined hormone replacement therapy (estradiol, 2 mg/d, and norethisterone acetate, 1 mg/d)
Trial: 2709206
Drug: Intravenous antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotic therapy (Group I)
Trial: 6103766
Drug: Synthetic LHRH
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic LHRH (HOE 471) administered intranasally for 4 weeks
Trial: 12001541
Drug: Subcutaneous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous enoxaparin
Trial: 22828032
Drug: Bolus feeding
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus feeding (Group A) administered in 10 minutes followed by continuous feeding for 3 hours.
Trial: 17164234
Drug: Prescribed medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescribed medications (average 3.7 prescribed medicines)
Trial: 17164234
Drug: Determinants predicting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Determinants predicting polypharmacy: breathlessness, hypertension, dependency on instrumental activities of daily living, low subjective health, medication disagreement between doctors and patients
Trial: 27881555
Drug: Dose-adjusted VKA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-adjusted VKA daily with DAPT stratification (group 3)
Trial: 27881555
Drug: Rivaroxaban 15
RxNorm normalized name: rivaroxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 15 mg daily plus P2Y12 inhibitor for 12 months (group 1)
Trial: 27881555
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg twice daily with DAPT stratification (group 2)
Trial: 24188941
Drug: Honey-flavored corn
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey-flavored corn syrup as placebo
Trial: 19282468
Drug: Docetaxel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (60 mg/m(2)/3 weeks)
Trial: 17578320
Drug: nmAP (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nmAP (1.5 ml on Shenque acupoint once daily, placebo liquid 10 ml twice daily)
Trial: 25125053
Drug: Ketorolac +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac + Acetazolamide (250 mg acetazolamide before anesthetic induction and 30 mg ketorolac in the immediate postoperative period)
Trial: 25125053
Drug: Ketorolac (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac (30 mg in the immediate postoperative period)
Trial: 19057629
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections with 0.5% lidocaine 9 mL mixed with 1 mL of steroid
Trial: 8741094
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg ketoprofen lysine salt
Trial: 2067317
Drug: Cyclandelate (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclandelate (1200 mg, single oral dosage)
Trial: 14572572
Drug: Prednisolone therapy
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone therapy
Trial: 16214825
Drug: Azathioprine therapy
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine therapy
Trial: 28232467
Drug: Internet-based cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive-behavioural writing therapy (IB-CBWT) for PTSD, guided by a therapist, comprising two written assignments per week over a 5-week period.
Trial: 28232467
Drug: Wait-list (WL)
RxNorm normalized name: semaglutide
DrugBank: Semaglutide (DB13928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Wait-list (WL) control group receiving treatment after a waiting period of 5 weeks.
Trial: 28232467
Drug: Internet-based cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive-behavioural writing therapy (IB-CBWT) for PTSD.
Trial: 25604313
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg (intensive)
Trial: 8431125
Drug: Electrosurgical dissection
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrosurgical dissection with 'L' hook and spatula electrodes at 25 W coagulation current
Trial: 3429696
Drug: Long-acting propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting propranolol 60 mg (LA 60 mg)
Trial: 3429696
Drug: Conventional propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional propranolol 20 mg tid
Trial: 30322091
Drug: Moringa oleifera
RxNorm normalized name: Moringa Oleifera
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moringa oleifera leaf powder (20 g)
Trial: 1610589
Drug: 5-day preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-day preoperative treatment with oral administration of 60 mg diltiazem 3 times daily, 10 mg diltiazem intravenously as a bolus dose before the beginning of the cardiopulmonary bypass, and 5 mg diltiazem intravenously 10 min before removal of aortic clamp
Trial: 1610589
Drug: 5-day preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-day preoperative treatment with oral administration of 60 mg diltiazem 3 times daily
Trial: 1610589
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg diltiazem intravenously as a bolus dose before the beginning of CPB and 5 mg 10 min before removal of the aortic clamp
Trial: 1610589
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg diltiazem in 1000 ml cardioplegic solution, given as additive
Trial: 24750904
Drug: Standard stroke-unit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard stroke-unit care without preventive antibiotic therapy
Trial: 20124169
Drug: High-dose radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radiation therapy (79.2 GyE)
Trial: 11886356
Drug: IVMP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVMP 2 g/day
Trial: 11886356
Drug: IVMP 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVMP 1 g/day
Trial: 7843440
Drug: Subdermal levonorgestrel‐releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subdermal levonorgestrel‐releasing implant
Trial: 1334803
Drug: Prinivil 10
RxNorm normalized name: Prinivil 10mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prinivil 10 to 40 mg once daily
Trial: 1334803
Drug: Procardia XL
RxNorm normalized name: Procardia XL
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Procardia XL 30 to 120 mg once daily
Trial: 6502311
Drug: Bovine superoxide
RxNorm normalized name: Superoxide dismutase (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine superoxide dismutase (0.25 mg/kg)
Trial: 9066005
Drug: ACEI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI treatment
Trial: 18653268
Drug: ARB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB treatment
Trial: 10543267
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg albendazole daily in three cycles of 6 weeks with 2 weeks between cycles
Trial: 28524039
Drug: Gubiao Pixie
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gubiao Pixie prescription (Radix Astragali 30 g, Bran fried Rhizoma Atracylodis 20 g, Raidix Saposhnikoviae 12 g, Radix Scutellariae 10 g, Fructus Tsaoko 6 g), taken in warm water 300 mL, twice a day after meals for 10 days.
Trial: 15307012
Drug: Triple-drug therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug therapy (indinavir + zidovudine or stavudine + lamivudine)
Trial: 15307012
Drug: Dual-drug therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-drug therapy (zidovudine or stavudine + lamivudine)
Trial: 7506324
Drug: Bimakalim (0.25-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimakalim (0.25-1 mg)
Trial: 2366172
Drug: Acetaminophen with
RxNorm normalized name: acetaminophen with codeine ORAL ELIXIR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen with codeine
Trial: 12891954
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous terbutaline infusion (SQ group)
Trial: 12891954
Drug: Oral tocolytics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tocolytics (PO group)
Trial: 8912763
Drug: Low serum
RxNorm normalized name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Glow Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low serum albumin (< 30 mg/dl)
Trial: 27701370
Drug: Intra-arterial administration
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial administration of iloprost (Endoprost®) after balloon angioplasty of below-the-knee vessels
Trial: 26783035
Drug: Carbon nanoparticles
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon nanoparticles injection around the primary tumor
Trial: 24599650
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection (control group)
Trial: 30616675
Drug: Intravenous sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sedation (midazolam, propofol)
Trial: 27847368
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated cholera vaccine CVD 103-HgR (Vaxchora)
Trial: 21157384
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg · kg(‐1))
Trial: 9562003
Drug: Pre‐to‐posttraining difference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐to‐posttraining difference in LVEF at peak dobutamine infusion
Trial: 8148354
Drug: Linoleate-enriched diet
RxNorm normalized name: linoleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linoleate-enriched diet with 1200 mg/d of alpha-tocopherol
Trial: 8148354
Drug: Oleate-enriched diet
RxNorm normalized name: oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oleate-enriched diet with 1200 mg/d of alpha-tocopherol
Trial: 8148354
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet with 1200 mg/d of alpha-tocopherol
Trial: 10866905
Drug: Fentanyl (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (dose per usual practice of the anesthesiologist)